nimesulide and 2,3-dinor-6-ketoprostaglandin f1alpha

nimesulide has been researched along with 2,3-dinor-6-ketoprostaglandin f1alpha in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belton, O; Byrne, D; Fitzgerald, DJ; Kearney, D; Leahy, A1
FitzGerald, GA; Li, H; Praticò, D; Tillmann, C; Zhang, ZB1

Trials

1 trial(s) available for nimesulide and 2,3-dinor-6-ketoprostaglandin f1alpha

ArticleYear
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
    Circulation, 2000, Aug-22, Volume: 102, Issue:8

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Epoprostenol; F2-Isoprostanes; Female; Humans; Isoenzymes; Macrophages; Male; Membrane Proteins; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Thromboxane A2; Thromboxane B2

2000

Other Studies

1 other study(ies) available for nimesulide and 2,3-dinor-6-ketoprostaglandin f1alpha

ArticleYear
Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Mar-13, Volume: 98, Issue:6

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Coronary Artery Disease; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Epoprostenol; Female; Indomethacin; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Prostaglandin-Endoperoxide Synthases; Receptors, LDL; Sulfonamides; Thromboxane B2

2001